NCT01541735View on ClinicalTrials.gov

Pantoprazole on Insulin Secretion in Diabetes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2013

Conditions
Type 2 Diabetes
Interventions
DRUG

Pantoprazole

The pantoprazole will be administered in capsules of 40mg. The dose will be 1 capsule per day during 45 days.

DRUG

placebo

Placebo 40 mg dose.

Trial Locations (1)

44380

Instituto Mexicano del Seguro Social. Hospital de Especialidades., Guadalajara

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT01541735 - Pantoprazole on Insulin Secretion in Diabetes | Biotech Hunter | Biotech Hunter